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Through its ability to induce the enhanced releaseand production of cytokines, amyloid-β is responsi-
ble for the chronic inflammatory response that
contributes to Alzheimer’s disease (AD). Determining
whether the response of monocytes to amyloid-β
stimulation is under genetic control may help under-
stand the basis of why some people are more prone
to develop neuronal degeneration than others. In the
current study we investigated the heritability of the
cytokine (IL-10, IL-6, IL-1β, IL-1ra, TNF-α) production
capacity upon ex vivo stimulation with amyloid-β in
whole blood samples of 222 twins and 85 singleton
siblings from 139 extended twin families. It was
found that individual differences in amyloid-β-
induced cytokine production capacity are to a large
extent of genetic origin, with heritability estimates
ranging from 55% (IL-1β) to 68% (IL-6). We con-
clude that genes influencing amyloid-β-induced
cytokine response may provide clues to the progres-
sion of AD pathology.
Senile plaques constitute the key pathological feature
of Alzheimer’s disease (AD) and are composed of insol-
uble amyloid-β (Aβ), activated microglia, astrocytes,
and degenerating neurons. The accumulation of
inflammatory microglia at sites of Aβ deposition signif-
icantly contributes to neuronal degeneration (McGeer
& McGeer, 1995). Aβ is able to initiate the accumula-
tion and activation of microglia by triggering the
complement cascade and induce enhanced release and
production of cytokines (Bornemann et al., 2001; Shen
& Meri, 2003). Aβ, itself, may induce a chronic
inflammatory response contributing to both further
plaque development and neuronal degeneration,
detectable in reactive microglia within senile plaques.
In twins, the concordance with diagnosed AD (up
to death) has been found to be two- to threefold
greater for monozygotic (MZ) than for dizygotic
(DZ) pairs, indicating strong genetic influences on the
presence of AD (Gatz et al., 1997). Also the age of
onset of AD has been shown to be under genetic
influence (Pedersen at al., 2001). The inflammatory
response to the presence of Aβ in the brain could
underly this heritable component in AD. In the
current twin study we therefore investigated whether
production capacity of cytokines upon stimulation
with Aβ is a heritable characteristic.
Microglia are derived from monocytic lineage and
arrive in the central nervous system (CNS) late in
embryonic development. Based on their lineages and
phenotype, microglial cells are generally accepted as
the macrophages of the CNS (Davis et al., 1992).
Hence, peripheral monocytes may be a useful model to
mimic the effects of Aβ peptides on human microglia
function in the brain. To determine the magnitude of
the heritability of the production capacity of cytokines
upon stimulation with Aβ, we examined in a sample of
MZ and DZ twin pairs and their siblings the cytokine
profiles upon ex vivo stimulation of whole blood
samples with lipopolysaccharide (LPS) and Aβ. This
design allows the determination of the extent to which
interindividual differences in Aβ-stimulated cytokine
production capacity can be ascribed to genetic differ-
ences between individuals. MZ twins share all, or
nearly all (Martin et al., 1997), of their genetic mater-
ial. DZ twins and siblings share on average 50% of
their segregating genes. If resemblances (often
expressed as correlations) in MZ pairs are larger than
in DZ pairs, this is a first indication that genetic influ-
ences are of importance (Martin et al., 1997; Posthuma
et al., 2004). The use of the so-called ‘extended’ twin
design (including twins and their siblings) ensures rela-
tive high statistical power to detect sources of
nongenetic, environmental variation that are shared by
family members (Posthuma & Boomsma, 2000).
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Previously we have shown that individual differences
in the cytokine production capacity of peripheral
monocytes upon lipopolysaccharide (LPS) stimulation
can be explained by genetic variation (de Craen et al.,
2005; Westendorp et al., 1997). Here we examine
whether such is also the case when cells are stimulated
by both LPS and Aβ.
Subjects and Methods
Subjects and Procedure
This study is part of a larger study on the genetics of
adult brain function (Posthuma et al., 2001). Twins and
their siblings were invited for an additional visit to the
lab for blood extraction. Three hundred and seven
twins and their siblings from 139 families participated.
The age range was 15.6 to 68.7 years (mean age = 38.7,
SD = 12.5). Forty-six per cent were males, and 54%
were females. The total sample included 41 MZ pairs,
52 DZ pairs, and one family consisting of trizygotic
triplets. In addition, 85 siblings participated and 33
single twins (who participated with a nontwin sibling).
Zygosity of same-sex twins was determined by typing
highly polymorphic genetic markers. Fasting blood
samples were drawn in the morning before 11.00 am.
All subjects gave informed consent and received a
breakfast after donating their blood sample. The study
was approved by the Medical Ethical Committee of the
Vrije Universtiy Amsterdam. All participants provided
written informed consent.
Cytokine Production Capacity
Cytokine production capacity was assessed with an ex
vivo whole blood assay, as described previously with
small alterations (de Craen et al., in press; van der
Linden et al., 1998). In short, heparinized whole
blood samples were first diluted fivefold with RPMI-
1640 (Gibco Life technologies). Then, samples were
stimulated with either 10 ng/ml LPS (from Escherichia
coli 0111, Difco Laboratories) alone or 10 ng/ml LPS
in combination with 50 U/ml Ab 1-42 fibrils (Bachem)
and incubated for 24 hours at 37°C with 5% CO2.
The amyloid was fibrilar as shown by green birefrin-
gence in a polarizing microscope after Congo red
staining. After centrifugation, the supernatants were
stored at –80°C until assaying for Interleukin-1β (IL-
1β), Interleukin-1ra (IL-1ra), Interleukin-6 (IL-6),
Interleukin-10 (IL-10), and Tumor Necrosis Factor-α
(TNF-α), using standard ELISA techniques according
to the manufacturers’ guidelines (Central Laboratory
of the Blood Transfusion Service, Amsterdam, the
Netherlands).
Stimulation of unactivated monocytes with Aβ
does not result in enhanced cytokine release. However,
Aβ induces increased release of cytokines from LPS-
activated human monocytes (Lorton et al., 1996).
Therefore, to assess the individual Aβ-induced
cytokine response the level of cytokine production
upon LPS alone was subtracted from production upon
LPS plus Aβ stimulation.
Statistical Analysis
Five subjects were excluded from the analyses: the
determination of the cytokine profile failed due to
technical problems in 2 subjects, and 3 subjects had
TNF-α concentrations of more than 100 pg/ml under
unstimulated conditions. The distribution of each
cytokine was inspected for outliers, which were subse-
quently eliminated from the analyses (3 outliers for
IL-1β, 2 for IL-6, and 1 for TNF-α). We tested for het-
erogeneity across zygosity and sex with respect to
means and variances. In addition, the effect of age on
the observed cytokine production scores was included
as a covariate.
Genetic Analyses
The data were first summarized into correlations for
MZ and DZ twin and sibling pairs. Next, the varia-
tion in cytokine response upon Aβ stimulation was
decomposed into additive genetic variation (A), shared
environmental variation (C) or nonshared environ-
mental variation (E; Boomsma et al., 2002; Posthuma
et al., 2004). Shared environmental variation by defin-
ition included all environmental sources of variation
that twins and siblings from the same family share,
while nonshared environmental variation refers to the
environmental variation that is unique for an individ-
ual and that is typically not shared with other family
members. For DZ twin and sibpairs similarity in
shared environmental influences is 100% and similar-
ity of additive genetic influences is 50%. There was by
definition no similarity in nonshared environmental
influences. For MZ twin pairs similarities of additive
genetic and shared environmental influences were
fixed at 100%. Thus, the expectation for the total
variance is A + C + E, the expectation for the covari-
ance between MZ twins is A + C, and the expectation
for DZ twins/sibpairs is 1⁄2A + C. Heritability is calcu-
lated as the proportional contribution of genetic
variation to the total observed variation. All analyses
were carried out using the statistical software package
Mx (Neale, 1997). Estimation of parameters was
obtained by normal theory maximum likelihood.
Testing of the significance of A and C was done by
constraining them at zero and comparing the resulting
fit of the model using likelihood ratio tests (Neale &
Cardon, 1992).
Results
The distributions of Aβ induced cytokine production
capacity is graphically represented in Figure 1. The dis-
tribution of the production capacity is wide, representing
both up and down regulation of individual samples.
Table 1 shows significant upregulation by Aβ for IL-
1β and significant downregulation for IL-1ra, IL-10,
IL-6, and TNF-α. No differences in variances or means
between MZ twins, DZ twins and sibling pairs were
found. Also, no such differences were found between
males and females except for a mean difference in IL-10
production. Men had a higher IL-10 production com-
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pared to women (+282.71 pg/ml; see Table 1). There
was no association with age for any of the cytokines.
The difference between cytokine production after LPS
stimulation and cytokine production after Aβ stimula-
tion was statistically different (p < .001) from zero for
all five cytokines.
Maximum likelihood estimates of twin and sibling
correlations are given in Table 2. No differences between
DZ twin correlations and sibling correlations were
found. MZ correlations ranged from .36 for Aβ-induced
regulation of TNF-α levels to .65 for Aβ-induced regula-
tion of IL-6 levels. DZ correlations were lower than the
MZ correlation, indicating the presence of genetic
factors in the Aβ-induced cytokine response.
Decomposition of the variation into additive
genetic, shared environmental and nonshared environ-
mental variation indicated that variation in Aβ
induced regulation of IL-10, IL-1β and IL-6 variation
was caused by additive genetic sources and nonshared
environmental sources. Heritabilities of IL-10 were
estimated at 58%, for IL-1β at 55% and for IL-6 at
67%. Genetic and shared evironmental sources of
variation could not be distinguished between for IL-
1ra and TNF-α, although the poor fit of the model
that included only nonshared environmental sources
of variation indicates that familial (i.e., genetic or
shared environmental) sources are important.
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Figure 1
Histograms of the production of cytokines (in pg/ml) upon stimulation of Aβ, calculated by subtracting the cytokine level after LPS stimulation from
the cytokine level after subsequent amyloid-β stimulation.
Table 1
Sample Descriptives 
N Mean SD
(pg/ml)
Males Aβ-induced production of IL-10 139 –351 970
(Mean age Aβ-induced production of IL-1ra 139 –2497 4774
38.29 years; Aβ-induced production of Il-1β 135 2982 4355
SD 12.30) Aβ-induced production of IL-6 137 –14,716 21,375
Aβ-induced production of TNF-α 138 –746 3002
Females Aβ-induced production of IL-10 163 –718 738
(Mean age Aβ-induced production of IL-1ra 163 –2725 4810
39.08 years; Aβ-induced production of Il-1β 163 3639 3642
SD 12.63) Aβ-induced production of IL-6 163 –13,012 19,711
Aβ-induced production of TNF-α 163 –585 2702
Note: Amyloid-β production capacity was calculated by subtracting the cytokine level
after LPS stimulation from the cytokine level after amyloid-β stimulation.
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In all cases, a model that included only nonshared
environmental influences provided a poor fit to the
data, as indicated by a significant p-value in the E
model (Table 3).
Discussion
The effects of Aβ on additional cytokine release from
ex vivo LPS-stimulated whole blood samples show
large individual differences. These differences were
found to be of genetic origin to a large extent, with her-
itability estimates ranging from 55% (IL-1β) to 68%
(IL-6). This implies that monocytes and possibly also
microglia have an innate cytokine response to the pres-
ence of Aβ. In other words, the chronic inflammatory
response to the presence of Aβ depends on an individ-
ual’s genetic background and may thus explain why
some individuals are more prone to develop reactive
microglia and continue on to develop AD than others.
In the past two decades several genes related to the
onset and progression of symptoms in AD have been
identified, such as ApoE, Presenilin-1, Presenilin-2,
Amyloid Precusor Protein (Corder et al., 1993; Goate
et al., 1991; Levy-Lahad et al., 1995; Rogaev et al.,
1995; Selkoe, 1996; Sherrington et al., 1995).
Together these genes account for roughly 10% of AD
prevalence. Futhermore, genetic variants within the
IL-1a, IL-1β and IL-1rn genes have been
associated/related to age of onset and progression of
symptoms of AD (Alvarez et al., 2002; Combarros et
al., 2002; Griffin & Mrak, 2002; Licastro et al., 2003;
Sciacca et al., 2003). Possibly these variants affect the
innate production capacity towards a pro-inflamma-
tory profile.
Cytokines play critical roles in the development
and progression of AD (Mrak et al., 1995), not only as
a consequence of the disease, but also as a precursor
to it. The presence of Aβ stimulates microglia, astro-
cytes and oligodendrocytes to secrete proinflammatory
cytokines, a very early step in the development of AD
(Mott et al., 2004; Tan et al., 1999). Recently, we
have shown that the production of cytokines in a LPS-
stimulated whole blood assay is under strict genetic
control (De Craen et al., in press). The present study
expands this evidence by showing that in healthy, non-
AD human subjects of middle age, the Aβ-induced
inflammatory response is also under genetic control.
It has been suggested that chronic inflammatory
responses contribute to the development of AD
pathology (Akiyama et al., 2000; Eikelenboom & van
Gool, 2004). Here we propose that the heritable com-
ponent in the rate of AD progression is partly
explained by the innate cytokine production capacity
of monocyte-derived cells. Our results warrant further
investigation of LPS/Aβ responses and variation in
cytokine and cytokine receptor genes in relation to AD
age of onset and progression.
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